Spotlight on Formulation: Quay Pharma Podcast

As part of our spotlight on formulation series, Maura McArdle and Audrey Vardy from Quay Pharma, share a discussion about Quay Pharma’s preclinical service and expertise in their recent podcast.

The podcast is the second in the QuayCast series, and provides a background to the services Quay Pharma offers. The podcast also talks about the solubility screen, which is carried out using a scientific and tailored approach; discussion where this sits in relation to animal studies and formulation development; the importance of involving a DMPK provider for initial PK studies; and how the services work for new chemical entities and new drug products as well as reformulations.

To listen to the podcast, click on the play button below:

 

Quay Pharma is one of XenoGesis’ carefully selected CDMO partners, as announced in a recent news story.

To find out more about formulation services from XenoGesis and its CDMO partners, click here.

If you’d like to get in touch with one of our scientists, please click here!